Evidence map›Paper›PMID 41499758›Full record

ArticleBlood advances2026

Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma.

Gloria Iacoboni, Emil Ramsø Kyvsgaard, Víctor Navarro Garcés, David A Russler-Germain, Katharine Lewis, Alejandro Martín García-Sancho, Itziar Carro, Philip A Thompson, Dylan Therwhanger, David Quintela and 23 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Gloria IacoboniDepartment of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.ORCID 0000-0003-0805-9288
Emil Ramsø KyvsgaardDepartment of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.ORCID 0009-0002-8549-7409
Víctor Navarro GarcésStatistics Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain.ORCID 0000-0001-6925-4605
David A Russler-GermainSiteman Cancer Center, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-1009-2247
Katharine LewisDepartment of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.ORCID 0000-0003-0549-5877
Alejandro Martín García-SanchoHospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, University of Salamanca, Salamanca, Spain.ORCID 0000-0001-6330-1028
Itziar CarroDepartment of Hematology, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.ORCID 0009-0002-2765-1113
Philip A ThompsonDepartment of Hematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0003-2086-6031
Dylan TherwhangerDepartment of Hematology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.ORCID 0009-0003-9423-1941
David QuintelaDepartment of Hematology, Instituto Catalán de Oncología-Instituto de Investigación contra la Leucemia Josep Carreras-Hospital Germans Trias i Pujol, Barcelona, Spain.
Matthew KuDepartment of Hematology, St Vincent's Hospital, Melbourne, Australia.ORCID 0000-0002-9289-1335
Pilar GómezDepartment of Hematology, Hospital La Paz, Madrid, Spain.ORCID 0009-0001-2412-0408
Evelyn ValenciaDepartment of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.ORCID 0000-0001-5998-6925
Gala VegaDepartment of Hematology, University Hospital Fundación Jiménez Díaz, Madrid, Spain.
Ana Jiménez-UbietoDepartment of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Mariana Bastos-OreiroDepartment of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID 0000-0002-9431-4646
Angel SernaDepartment of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.ORCID 0000-0001-7532-9634
Simon HusbyDepartment of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-6332-1173
Beatriz De La CruzDepartment of Hematology, Hospital La Paz, Madrid, Spain.ORCID 0000-0002-3223-0121
Jing LuanSiteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Sergi CamarillasDepartment of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.ORCID 0009-0002-3229-9003
Lucía MedinaDepartment of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID 0009-0000-5081-8466
Almudena CaberoHospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, University of Salamanca, Salamanca, Spain.
Raúl CórdobaDepartment of Hematology, University Hospital Fundación Jiménez Díaz, Madrid, Spain.
Miguel CanalesDepartment of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.ORCID 0000-0002-6550-2621
Juan-Manuel SanchoDepartment of Hematology, Instituto Catalán de Oncología-Instituto de Investigación contra la Leucemia Josep Carreras-Hospital Germans Trias i Pujol, Barcelona, Spain.ORCID 0000-0001-7168-6538
Francesc BoschDepartment of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
Anna SuredaDepartment of Hematology, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.ORCID 0000-0002-1238-6970
Stephen SchusterDepartment of Hematology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-3376-8978
Chan Y CheahDepartment of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.ORCID 0000-0001-7988-1565
Martin HutchingsDepartment of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-3873-1741
Pere BarbaDepartment of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
Pau AbrisquetaDepartment of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41499758
PMCPMC12995481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.